EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Kinase Signaling in Glioblastoma: Structural Optimization, Blood–Brain Barrier Dynamics and Combinatorial Translational Strategies

Diana Juanes-Gusano iD, Beatriz Fernández-Roldán iD, Rafael Coveñas iD, Maruan Hijazi iD

International Journal of Molecular Sciences · 24.07.2026 · 27 (15) · 6590

DOI: 10.3390/ijms27156590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.07.2026. Verfasst von Diana Juanes-Gusano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Group USAL-BMD (Bases Moleculares del Desarrollo), University of Salamanca, 37007 Salamanca, Spain. Hauptthemen laut MEDLINE: Glioblastoma, Blood-Brain Barrier, Signal Transduction, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Ministry of Science and Information, Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small-molecule kinase inhibitors offer a compelling therapeutic strategy for glioblastoma, yet their clinical efficacy remains severely limited by blood–brain barrier penetration and active efflux transporter extrusion. This review evaluates current medicinal chemistry approaches and translational paradigms to overcome these drug delivery and biological constraints. A critical analysis of the literature reveals that direct structural optimization faces a multidimensional balancing act; next-generation design must prioritize macrocyclization, structural rigidification, and bioisosteric capping to lower polar surface area and evade P-glycoprotein and BCRP efflux. Furthermore, carrier-mediated prodrugs targeting the LAT1 transporter provide a viable rescue strategy for highly potent scaffolds. Reviewing recent clinical failures, such as paxalisib and osimertinib, underscores that single-node monotherapies fail due to compensatory pathway hyperactivation and clonal heterogeneity, whereas multi-targeted agents or rational dual-node combinations prevent rapid tumor adaptation. Additionally, combining kinase inhibitors with DNA damage repair inhibitors, immune checkpoint modulation, or MR-guided focused ultrasound could provide powerful synergistic networks. Finally, bridging the translational gap requires complementing conventional serum-cultured cell lines with patient-derived glioma stem cells and orthotopic xenografts to better recapitulate the cellular architecture of the disease. Ultimately, overcoming the therapeutic challenges in glioblastoma demands a fundamental pivot toward rigorous neuro-pharmacological design and multi-lineage network oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBlood-Brain BarrierSignal TransductionProtein Kinase InhibitorsBrain NeoplasmsAntineoplastic AgentsHumansAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

blood–brain barriercombinatorial therapyefflux transportersglioblastomakinase inhibitorspatient-derived xenograftsprodrugsstructural optimization

Substanzen

Protein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Group USAL-BMD (Bases Moleculares del Desarrollo), University of Salamanca, 37007 Salamanca, Spain.
  • Institute of Neuroscience of Castilla and León (INCyL), iBRAINS-IN-CyL, 37007 Salamanca, Spain.
  • Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.

ORCID-Profile: Diana Juanes-Gusano, Beatriz Fernández-Roldán, Rafael Coveñas, Maruan Hijazi

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Ministry of Science and Information
  • Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación

Zitieren

APA

Juanes-Gusano, D., Fernández-Roldán, B., Coveñas, R., & Hijazi, M. (2026). Targeting Kinase Signaling in Glioblastoma: Structural Optimization, Blood–Brain Barrier Dynamics and Combinatorial Translational Strategies. International Journal of Molecular Sciences, 27(15), 6590. https://doi.org/10.3390/ijms27156590

Vancouver

Juanes-Gusano D, Fernández-Roldán B, Coveñas R, Hijazi M. Targeting Kinase Signaling in Glioblastoma: Structural Optimization, Blood–Brain Barrier Dynamics and Combinatorial Translational Strategies. International Journal of Molecular Sciences. 2026;27(15):6590. doi:10.3390/ijms27156590

BibTeX
@article{JuanesGusano2026,
  author = {Juanes-Gusano, Diana and Fernández-Roldán, Beatriz and Coveñas, Rafael and Hijazi, Maruan},
  title = {Targeting Kinase Signaling in Glioblastoma: Structural Optimization, Blood–Brain Barrier Dynamics and Combinatorial Translational Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6590},
  doi = {10.3390/ijms27156590}
}
Kostenlos starten →